Skip to content

Upstream Bio, Inc. UPB Ratios & Valuation

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Profitability
Operating margin-5,176.5%-1,049pp-5,618.8%-2,338pp-5,020.1%-2,040pp-4,464.6%-1,931pp-4,127.4%
Net margin-4,719%-1,270pp-5,026%-2,376pp-4,366.8%-1,947pp-3,836.6%-2,013pp-3,448.7%
EBITDA margin-5,170.7%-1,048pp-5,612.2%-2,335pp-5,013.6%-2,036pp-4,459.2%-4,122.2%
Returns
Return on equity-41.8%-35.4%
Return on assets-40.5%-34.3%-13.4pp-39.2%
Return on invested capital-58.9%-83.2%
Efficiency
Asset turnover0.0×
Liquidity
Current ratio23.1×-24.3×26.2×-18.5×32.7×+11.8×38.3×47.4×
Quick ratio23.1×-24.3×26.2×-18.5×32.7×+11.8×38.3×47.4×
Cash ratio7.1×-0.4×7.6×-22.8×6.1×+3.0×4.2×7.5×
Leverage
Debt-to-equity0.0×0.0×
Debt-to-assets0.0×0.0×0.0×
Per Share
Book value per share$5.60-32.7%$6.31-81.6%$7.02+113%$7.60+116%$8.31+119%
Valuation
Market capitalization$346.11M-40.9%$1.47B+66.5%$1.01B$612.71M$328.28M
Enterprise value$250.5M-51.4%$1.37B+145%$943.29M$568.81M$258.67M
Price / sales104.2×-151×514.1×+142×362.3×225×143×
Price / book1.1×-0.2×4.3×+2.4×2.7×1.5×0.7×
EV / sales75.4×-149×478.9×+244×337×208.9×112.7×
Earnings yield-45.3%-31.8pp-9.8%-2.6pp-12.1%-17.1%-24.1%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Upstream Bio, Inc.'s ratios come from?
Every ratio is computed from Upstream Bio, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.